AMP 203
Alternative Names: AMP-203Latest Information Update: 07 Sep 2023
At a glance
- Originator Amplifica
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Alopecia